Klotho Therapeutics has a total of 44 patents globally, out of which 6 have been granted. Of these 44 patents, more than 81% patents are active. Japan & South Korea is where Klotho Therapeutics has filed the maximum number of patents, followed by United States of America. Parallelly, the USA seems to be the main focused R&D center of Klotho Therapeutics and is also the origin country of the firm.
Klotho Therapeutics was founded in the year 2016 by James Plante. The company is focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Do read about some of the most popular patents of Klotho Therapeutics which have been covered by us in this article and also you can find Klotho Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Klotho Therapeutics patent portfolio.
How many patents does Klotho Therapeutics have?
Klotho Therapeutics has a total of 44 patents globally. These patents belong to 6 unique patent families. Out of 44 patents, 36 patents are active.
How Many Patents did Klotho Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Klotho Therapeutics Applications Filed | Klotho Therapeutics Patents Granted |
| 2022 | 3 | 1 |
| 2021 | 8 | – |
| 2020 | 1 | – |
| 2019 | 1 | – |
| 2018 | 9 | – |
| 2017 | 20 | – |
| 2016 | – | – |
How many Klotho Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Klotho Therapeutics File in Different Countries?
Countries in which Klotho Therapeutics Filed Patents
| Country | Patents |
| Japan | 6 |
| Korea (South) | 6 |
| United States Of America | 5 |
| Canada | 4 |
| Australia | 4 |
| Europe | 4 |
| China | 3 |
| Brazil | 2 |
| Mexico | 2 |
Where are Research Centres of Klotho Therapeutics Patents Located?
The R&D Centres of patents filed by Klotho Therapeutics is in the US.
Most Cited Klotho Therapeutics Patent
US20190169593A1 is the most popular patent in the Klotho Therapeutics portfolio. It has received 9 citations so far from companies like Catalyst Biosciences.
List of Klotho Therapeutics Patents
| Klotho Therapeutics Patents | Title |
| US20230279006A1 | Novel Compounds And Methods For Increasing Klotho Gene Expression |
| US20230278953A1 | Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury |
| US20210371839A1 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| US20200181224A1 | Novel Recombinant Klotho Proteins And Compositions And Methods Involving Same |
| US20190169593A1 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| EP4178560A1 | Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury |
| EP3720474A4 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| EP3551212A4 | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| EP3464608A4 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| CN116478907A | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Thereof |
| CN109996555A | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| CN109219663A | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| WO2023283648A1 | Novel Combinatorial Antitumor Treatment Methods And Related Compositions, Kits, And Systems |
| AU2017363321B2 | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| AU2017272349B2 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| AU2021305330A1 | Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury |
| AU2018378802A1 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| CA3185103A1 | Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury |
| CA3101100A1 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| CA3041910A1 | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| CA3025461A1 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| JP7290340B2 | Products And Methods For Assessing And Improving Klotho Protein Levels |
| JP7244923B2 | Novel Recombinant Klotho Protein And Compositions Containing Same |
| JP2023123565A | Therapeutic Recombinant Klotho Protein And Compositions And Methods Comprising The Same |
| JP2023113737A5 | Products And Methods For Assessing And Improving Klotho Protein Levels |
| JP2023533986A | A Water-Soluble Prodrug Of Ptba For Use In Hdac Inhibition And Promoting Renal Recovery After Acute Kidney Injury |
| KR102570250B1 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving Them |
| KR1020230125857A | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| KR1020230093531A | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| KR1020230039680A | Water-Soluble Prodrug Of Ptba For Use In Inhibiting Hdac And Enhancing Renal Recovery After Acute Kidney Injury |
| KR1020200095538A | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| KR1020190088988A | Novel Recombinant Klotho Proteins And Compositions And Methods Containing Same |
| MX404596B | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving Them. |
| BR112019010250A2 | New Recombinant Klotho Proteins And Compositions And Methods Involving Them |
| MX2019005687A | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same. |
| BR112018073909A2 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| WO2022217255A1 | Novel Antitumor Compounds And Related Methods Of Manufacture And Use |
| WO2022178544A1 | Novel Heterocyclic Compounds And Related Methods Of Manufacture And Use In Hdac Inhibition |
| WO2022011171A1 | Novel Compounds And Methods For Increasing Klotho Gene Expression |
| WO2022011174A1 | Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury |
| WO2019113373A3 | Products And Methods For Assessing And Increasing Klotho Protein Levels |
| WO2018098375A1 | Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| WO2017210607A1 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same |
| JP2019526272A5 | Therapeutic Recombinant Klotho Proteins And Compositions And Methods Containing The Same |
What are Klotho Therapeutics’ key innovation segments?
What Technologies are Covered by Klotho Therapeutics?
The chart below distributes patents filed by Klotho Therapeutics